Alpha-tocopherol in the ventricular cerebrospinal fluid of Parkinson's disease patients: Dose-response study and correlations with plasma levels

Neurology

Volumn 47, Issue 4, 1996, Pages 1037-1042

  Pappert, E J ^a   Tangney, C C ^a   Goetz, C G ^a   Ling, Z D ^a   Lipton, J W ^a   Stebbins, G T ^a   Carvey, P M ^a  

^a RUSH UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA TOCOPHEROL;

ARTICLE; BLOOD BRAIN BARRIER; CEREBROSPINAL FLUID ANALYSIS; CLINICAL ARTICLE; DOSE RESPONSE; DRUG EFFICACY; HUMAN; HUMAN CELL; HUMAN TISSUE; NEUROPROTECTION; ORAL DRUG ADMINISTRATION; PARKINSON DISEASE; PRIORITY JOURNAL; VITAMIN BLOOD LEVEL; VITAMIN INTAKE;

EID: 0029809527     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/WNL.47.4.1037     Document Type: Article

References (36)

1. Olanow CW. Oxidation reactions in Parkinson's disease. Neurology 1990;40(suppl3):32-37.
2. Fahn S, Cohen G. The oxidant stress hypothesis in Parkinson's disease: evidence supporting it. Ann Neurol 1992;32: 804-812.
3. Férnandez-Calle P, Molina JA, Jiménez-Jiménez FJ, et al. Serum levels of alpha-tocopherol (vitamin E) in Parkinson's disease. Neurology 1992;42:1064-1066.
4. Dexter DT, Ward RJ, Wells FR, et al. α-Tocopherol levels in brain are not altered in Parkinson's disease. Ann Neurol 1992; 32:591-593.
5. Fahn S. A pilot trial of high-dose alpha-tocopherol and ascorbate in early Parkinson's disease. Ann Neurol 1992;32:S128-S132.
6. Parkinson Study Group. Effects of tocopherol and deprenyl on the progression of disability in early Parkinson's disease. N Engl J Med 1989;321:1364-1371.
7. Vatassery GT, Brin MF, Fahn S, Kayden HJ, Traber MG. Effect of high doses of dietary vitamin E on the concentrations of vitamin E in several brain regions, plasma, liver, and adipose tissues of rats. J Neurochem 1988;51:621-623.
8. Pillai SR, Traber MG, Steiss JE, Kayden HJ, Cox NR. Alpha-tocopherol concentrations of the nervous system and selected tissues of adult dogs fed three levels of vitamin E. Lipids 1993;28:1101-1105.
9. Brin MF, Fahn S, Loftus S, McMahon D, Flaster E. Relationship between dose of vitamin E administered and blood levels. Ann NY Acad Sci 1989;570:421-424.
10. Dimitrov NV, Meyer C, Gilliland D, Ruppenthal M, Chenoweth W, Malone W. Plasma tocopherol concentrations in response to supplemental vitamin E. Am J Clin Nutr 1991;53: 723-729.
11. Meydani SN, Meydani M, Rail LC, Morrow F, Blumberg JB. Assessment of the safety of high-dose, short-term supplementation with vitamin E in healthy older adults. Am J Clin Nutr 1994;60:704-709.
12. Handelman GJ, Epstein WL, Peerson J, Spiegelman D. Human adipose alpha-tocopherol and gamma-tocopherol kinetics during and after 1 y of alpha-tocopherol supplementation. Am J Clin Nutr 1994;59:1025-1032.
13. Tangney CC, McCloskey KM, Aye PL. Effects of hyperoxia and diet on murine tissue levels of vitamin E and polyunsaturated fatty acids. Lipids 1988;23:707-712.
14. Vatassery GT, Smith WE, Quach HT. A liquid Chromatographic method for the simultaneous determination of alpha-tocopherol and tocopherol quinone in human red blood cells and other biological samples where tocopherol is easily oxidized during sample treatment. Anal Biochem 1993;214:426-430.
15. Benet LZ, Mitchell JR, Sheiner LB. Pharmacokinetics: the dynamics of drug absorption, distribution, and elimination. In: Goodman Gilman A, Rall TW, Nies AS, Taylor P, eds. The pharmacological basis of therapeutics. 8th ed. New York: Pergamon Press, 1990:3-33.
16. Clevidence BA, Ballard-Barbash R. Tocopherol contents of lipoproteins from frozen plasma separated by affinity chromatography. Lipids 1991;26:723-728.
17. Tangney CC, Tanner CM, DiSanto K, Goetz CG, Thelen J. Adipose tocopherol levels as a measure of chronic dietary vitamin E intake. Am J Clin Nutr 1991;53:101a.
18. Vatassery GT, Krezowski AM, Eckfeldt JH. Vitamin E concentrations in human blood plasma and platelets. Am J Clin Nutr 1983;37:1020-1024.
19. Bieri JG, Hoeg JM, Schaefer EJ, Zech LA, Brewer HB Jr. Vitamin A and vitamin E replacement in abetalipoproteinemia. Ann Intern Med 1984;100:238-239.
20. Princen HM, van Duyvenvoorde W, Buytenhek R, et al. Supplementation with low doses vitamin E protects LDL from Iipid peroxidation in men and women. Arterioscler Thromb Vase Biol 1995;15:325-333.
21. Kayden HG, Traber MG. Absorption, lipoprotein transport, and regulation of plasma concentration of vitamin E in humans. J Lipid Res 1993;34:343-358.
22. Vatassery GT, Nelson MJ, Maletta GJ, Kuskowski MA. Vitamin E (tocopherols) in human cerebrospinal fluid. Am J Clin Nutr 1991;53:95-99.
23. Toghi H, Abe T, Saheki M, Hamato F, Sasaki K, Takahashi S. Reduced and oxidized forms of glutathione and α-tocopherol in the cerebrospinal fluid of parkinsonian patients: comparison between before and after L-dopa treatment. Neurosci Lett 1995;184:21-24.
24. Wester P, Bergstrom U, Eriksson A, Gezelius C, Hardy J, Winblad B. Ventricular cerebrospinal fluid monoamine transmitter and metabolite concentrations reflect human brain neurochemistry in autopsy cases. J Neurochem 1990;54:1148-1156.
25. Weisner B, Bernhardt W. Protein fractions of lumbar, cisternal and ventricular cerebrospinal fluid. J Neurol Sci 1978;37: 205-214.
26. Keep RF, Cawkwell RD, Jones HC. The development of the blood-cerebrospinal fluid barrier: the relationship between structure and function in the rat choroid plexus. In: Suckling AJ, Rumsby MG, Bradbury MWB, eds. The blood-brain barrier in health and disease. Chichester, England: Ellis Horwood, 1986:41-50.
27. Crone C. The blood-brain barrier: a modified tight epithelium. In: Suckling AJ, Rumsby MG, Bradbury MWB, eds. The blood-brain barrier in health and disease. Chichester, England: Ellis Horwood, 1986:18-49.
28. Pardridge WM, Mietus LJ. Transport of steroid hormones through the rat blood-brain barrier. J Clin Invest 1979;61: 145-154.
29. Pitas RE, Boyles JK, Lee SH, Hui D, Wisegraber KH. Lipoproteins and their receptors in the central nervous system. J Biol Chem 1987;262:14352-14360.
30. Vatassery GT, Angerhofer CK, Know CA, Deshmukh DS. Concentrations of vitamin E in various neuroanatomical regions and subcellular fractions, and the uptake of vitamin E by specific areas of rat brain. Biochim Biophys Acta 1984;792: 118-122.
31. Vatassery GT, Angerhofer CK, Peterson FJ. Vitamin E concentrations in the brains and some selected peripheral tissues of selenium-deficient and vitamin E-deficient mice. J Neurochem 1984;42:554-448.
32. Adams JD, Wang B. Vitamin E uptake into the brain and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine toxicity. J Cereb Blood Flow Metab 1994;14:362-363.
33. Fishman RA. Exchange of albumin between plasma and cerebrospinal fluid. Am J Physiol 1953;175:96-98.
34. Dencker SJ, Swahn B. Clinical value of protein analysis in cerebrospinal fluid. A micro-immunoelectrophoretic study. Lund: Universitets Arsskrift, 1961.
35. Dencker SJ, Swahn B. The diagnostic value of lipoprotein determinations in cerebrospinal fluid. Acta Psychiatr Scand 1961;36:325-336.
36. Yoshikawa T, Yamaguchi K, Kondo M, Mizukawa N, Ohta T, Hirakawa K. Thiobarbituric acid reactive substances and vitamin E in serum and cerebrospinal fluid from patients with cerebral apoplexy. Arch Gerontol Geriatr 1982;1:209-218.